Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate
Katsuji Aikawa(Takeda (Japan)), Atsushi Hasuoka(Takeda (Japan)), Takashi Santou(Takeda (Japan)), Noriyuki Habuka, Koji Ono(Takeda (Japan)), Jason K. Yano(Fleet Science Center), Megumi Morimoto(Takeda (Japan)), Takahito Hara(Takeda (Japan)), Moriteru Asano(Takeda (Japan)), Keith P. Wilson(University of Alabama at Birmingham), Hitoshi Kandori(Takeda (Japan)), Masuo Yamaoka, Hisashi Fujita
Cited by 40
Related Papers
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
|Journal of Biological Chemistry|2011|441
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
|PubMed|2003|427
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine Scaffold
|Journal of Medicinal Chemistry|2011|223
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer
|Journal of Medicinal Chemistry|2021|205
Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
|Proceedings of the National Academy of Sciences|2018|172